Manufacturers Life Insurance Company, The Ptc Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$103 Billion
Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 41,136 shares of PTCT stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,136

Previous 65,654 37.34%

Holding current value

$1.26 Million

Previous $1.81 Million 33.89%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $592,109 - $783,350	-24,518 Reduced 37.34%	41,136 $1.2 Million
Q4 2023 Feb 13, 2024	SELL	$18.07 - $29.37 $2,945 - $4,787	-163 Reduced 0.25%	65,654 $1.81 Million
Q3 2023 Nov 15, 2023	SELL	$22.41 - $41.99 $353,809 - $662,938	-15,788 Reduced 19.35%	65,817 $1.47 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $1.4 Million - $2.05 Million	34,615 Added 73.66%	81,605 $3.32 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $381,638 - $488,648	10,001 Added 21.28%	56,991 $2.76 Million

Q4 2022 Aug 11, 2023	SELL	$33.53 - $54.79 $118,997 - $194,449	-3,549 Reduced 7.02%	46,990 $1.79 Million
Q4 2022 Feb 13, 2023	SELL	$33.53 - $54.79 $118,997 - $194,449	-3,549 Reduced 7.02%	46,990 $1.79 Million
Q3 2022 Aug 11, 2023	SELL	$41.85 - $53.85 $20,799 - $26,763	-497 Reduced 0.97%	50,539 $2.54 Million
Q3 2022 Nov 03, 2022	SELL	$41.85 - $53.85 $20,799 - $26,763	-497 Reduced 0.97%	50,539 $2.54 Million
Q2 2022 Aug 11, 2023	SELL	$25.6 - $45.23 $11,136 - $19,675	-435 Reduced 0.85%	51,036 $2.04 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $11,136 - $19,675	-435 Reduced 0.85%	51,036 $2.05 Million
Q1 2022 Aug 11, 2023	SELL	$33.33 - $44.6 $183,981 - $246,192	-5,520 Reduced 9.69%	51,471 $1.92 Million
Q1 2022 May 20, 2022	BUY	$33.33 - $44.6 $532,246 - $712,217	15,969 Added 44.98%	51,471 $1.92 Million
Q4 2021 Feb 16, 2022	SELL	$35.36 - $41.86 $6,859 - $8,120	-194 Reduced 0.54%	35,502 $1.42 Million
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $125,056 - $151,176	-3,379 Reduced 8.65%	35,696 $1.33 Million
Q2 2021 Aug 12, 2021	BUY	$37.95 - $49.37 $160,262 - $208,489	4,223 Added 12.12%	39,075 $1.65 Million
Q1 2021 May 03, 2021	SELL	$46.8 - $68.92 $99,543 - $146,592	-2,127 Reduced 5.75%	34,852 $1.65 Million
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $62,300 - $87,864	1,299 Added 3.64%	36,979 $2.26 Million
Q3 2020 Nov 09, 2020	SELL	$45.41 - $57.07 $46,726 - $58,725	-1,029 Reduced 2.8%	35,680 $1.67 Million
Q2 2020 Aug 10, 2020	SELL	$42.56 - $54.98 $64,691 - $83,569	-1,520 Reduced 3.98%	36,709 $1.86 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $126,016 - $231,088	3,893 Added 11.34%	38,229 $1.71 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $33,927 - $52,723	-1,053 Reduced 2.98%	34,336 $1.65 Million
Q3 2019 Nov 12, 2019	BUY	$33.82 - $48.17 $5,647 - $8,044	167 Added 0.47%	35,389 $1.23 Million
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $64,216 - $81,585	1,813 Added 5.43%	35,222 $1.59 Million
Q1 2019 May 13, 2019	BUY	$28.09 - $39.49 $152,135 - $213,877	5,416 Added 19.35%	33,409 $1.26 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $42,865 - $66,834	-1,437 Reduced 4.88%	27,993 $961,000
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $135,972 - $191,605	-4,011 Reduced 11.99%	29,430 $1.38 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $89,307 - $166,383	3,475 Added 11.6%	33,441 $1.13 Million
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $16,447 - $30,699	-942 Reduced 3.05%	29,966 $811,000
Q4 2017 Feb 08, 2018	BUY	$15.14 - $20.89 $545 - $752	36 Added 0.12%	30,908 $516,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $518,958 - $667,143	30,872	30,872 $618,000

Others Institutions Holding PTCT

# of Institutions

198

Shares Held

83.7M

Call Options Held

192K

Put Options Held

129K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.19B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Ptc Therapeutics, Inc. Transaction History